A phase 3 study of induction treatment with concurrent chemoradiotherapy versus chemotherapy before surgery in patients with pathologically confirmed N2 stage IIIA nonsmall cell lung cancer (WJTOG9903)-Reference-Cited by-同舟云学术

A phase 3 study of induction treatment with concurrent chemoradiotherapy versus chemotherapy before surgery in patients with pathologically confirmed N2 stage IIIA nonsmall cell lung cancer (WJTOG9903)

Published:2012-06-06 Issue:24 Volume:118 Page:6126-6135
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Katakami Nobuyuki,Tada Hirohito,Mitsudomi Tetsuya,Kudoh Shinzoh,Senba Hiroshi,Matsui Kaoru,Saka Hideo,Kurata Takayasu,Nishimura Yasumasa,Fukuoka Masahiro

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference20 articles.

1. Revisions in the international system for staging lung cancer;Mountain;Chest.,1997

2. Japanese Joint Committee of Lung Cancer Registry. Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study;Goya;Lung Cancer.,2005

3. Induction chemotherapy for locally advanced non-small cell lung cancer;Shepherd;Ann Thorac Surg.,1993

4. Randomized trial of neoadjuvant therapy for lung cancer: interim analysis;Pass;Ann Thorac Surg.,1992

5. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer;Rosell;N Engl J Med.,1994

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updated review of perioperative treatment for non-small-cell lung cancer in the new era of immune checkpoint inhibitors: past, present, and future;Japanese Journal of Clinical Oncology;2024-08-20

2. Induction therapy for non–small cell lung cancer;The Journal of Thoracic and Cardiovascular Surgery;2024-08

3. Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis;Cancers;2024-07-08

4. Multimodality treatment planning using the Markov decision process: a comprehensive study of applications and challenges;Research on Biomedical Engineering;2024-05-28

5. Adjuvant Pembrolizumab in Patients with Stage IIIA/N2 Non-Small Cell Lung Cancer Completely Resected after Neoadjuvant Concurrent Chemoradiation: A Prospective, Open-Label, Single-Arm, Phase 2 Trial;Cancer Research and Treatment;2024-04-30